-
13 of the latest endocrinology guidelines/consensus, included in one article December guideline update
Time of Update: 2023-02-03
cn/guideline/275552022 ISPAD Clinical Practice Consensus Guidelines: Insulin Treatment for Children and Adolescents with Diabetes (International)This article updates the insulin therapy section to include new pill and basal insulin formulations, detailed recommendations for the principles of intensive insulin regimens, an introduction to the role and rationale of insulin analogues, biosimilars, and diabetes technology devices in the treatment of pediatric diabetes, and presents key considerations for insulin accessibility and affordability.
-
Primary immune thrombocytopenia needs to be "treated" according to the person, and the first-line, second-line, and third-line treatment methods are summarized here
Time of Update: 2023-02-01
Poke "Read Original" to see moreWhen it comes to primary immune thrombocytopenia (ITP), doctors and friends must be familiar with it, "at least 2 consecutive blood routine tests show a decrease in platelet count (< 100×109/L) [1]" The incidence is about (2~10)/100,000 people, and most of the people over 60 years old and women of childbearing age [2, 3].
-
The overall performance of pharmaceutical listed companies in the third quarter was good, and nearly 70% of the company's revenue increased year-on-year
Time of Update: 2023-01-05
From the perspective of subdivisions, the medical device sector showed a high prosperity; The trend of micro-profit in the pharmaceutical business sector continued; The differentiation between the revenue capacity and R&D strength of the traditional Chinese medicine sector is obvious.
-
The biomedical sector bottomed out, and the agency suggested further increasing allocation
Time of Update: 2022-12-29
In January, the "14th Five-Year Plan" for the development of the pharmaceutical industry was released, the main content of which is to strengthen the research of key core technologies and vigorously promote the research and development of innovative products.
-
HBM-Shang Huifang's research group used functional imaging technology to reveal markers of motor progress in Parkinson's disease
Time of Update: 2022-11-04
Written by - responsible editor - Wang Sizhen, Fang Yiyi Editor—Summer LeafParkinson's disease (PD) is one of the most common neurodegenerative diseases [1]. Patients with PD develop a range of motor
-
343 varieties have passed the preliminary review and are included in the 2022 medical insurance directory, and the four highlights are the first to see! (Attached list
Time of Update: 2022-10-02
On September 6, the National Medical Insurance Bureau released the "List of Drugs and Related Information Approved by the Preliminary Form Review of the 2022 National Medical Insurance Drug Catalogue", and a total of 344 varieties passed the preliminary examination, including 199 Western medicines and proprietary Chinese medicines outside the list, and 145 Western medicines and proprietary Chinese medicines in the directory, with a publicity time of one week (as of 12 days).
-
Blue Sail Medical: 2.5 billion pieces of health protection nitrile gloves project has been put into production successfully
Time of Update: 2022-08-25
5 billion health protection (nitrile gloves) project" production line achieved a successful start-up on September 20 and was successfully put into production According to the announcement of Blue Sail Medical on the evening of September 21, the company's "third-phase annual output of 2.
-
Dongshun Group: The key technical achievements of new plant fiber filtration and adsorption composite materials passed expert demonstration
Time of Update: 2022-06-16
? According to reports, the plant fiber filtration and adsorption composite new material project has broken through the major technical problems of the safety protection industry "stuck neck", can replace the existing meltblown cloth and non-woven fabric in the medical and health field, and can also be used to replace air filter materials , Medical protective materials, automotive interior materials and water purification adsorption materials, etc.
-
A group of medical companies released a quarterly report, and the revenue generally showed an increasing trend
Time of Update: 2022-05-10
The first quarterly report of 2022 shows that in the first quarter of this year, Mindray Medical’s investment in research and development reached 742 million yuan, accounting for 10.
-
In the 100 billion medical device market, many companies have entered the market
Time of Update: 2022-05-10
[Pharmaceutical Network Market Analysis] In recent years, China's medical device industry is maintaining steady growth .
With the continuous development of the economic level and the increasing demand for health, China's medical device market will undoubtedly usher in huge development opportunities .
-
In 2021, the balance of medical insurance funds will reach a new high, and there will be no worries in the short term
Time of Update: 2022-04-27
Figure 4: 2018-2021 China's basic medical insurance fund (including maternity insurance) total income unit (100 million yuan) Source: National Medical Security Administration, Zhongkang Industrial Capital Research Center organized medical insurance fund expenditure in the past 4 years with a compound annual growth rate of 10.
-
Molecules produced by cells in response to stress may be indicators of various diseases
Time of Update: 2022-04-15
A new study led by researchers at Massachusetts General Hospital (MGH) and published in the journal Advanced Science shows that cells normally release certain RNA molecules called tDRs, In response to stressors, different tDRs may act as markers of cellular stress in different diseases .
-
Evaluation of the implementation of coronary stent centralized procurement: the comments of medical institutions have become an important indicator
Time of Update: 2022-01-25
The notice mentioned that the assessment objects are the city's medical insurance designated medical institutions (referred to as "medical institutions") that participate in the centralized procurement of coronary stents organized by the state, excluding those who did not participate in the report in the first year but purchased, and newly participated in the following year.
-
Nature Sub-Journal: A new target for tuberculosis treatment
Time of Update: 2022-01-10
Sabine Ehrt, professor of microbiology and immunology at Weill Cornell Medicine and senior author, said: "This enzyme is an attractive drug target for the treatment of tuberculosis-silencing it not only starves the bacteria, but also has additional toxicity to it.
-
Can a proton pump inhibitor be prescribed for functional dyspepsia
Time of Update: 2021-10-22
Only for medical professionals to read and refer to clinical information, 1s to reach more cutting-edge clinical information, follow the clinical pharmacy channel to obtain the source of this article
